Clinical Trials Directory

Trials / Terminated

TerminatedNCT02020356

Music Therapy in Alzheimer's Disease

Impact of Music Therapy on Prescription of Neuroleptics in Alzheimer's Disease ou Related Symptoms Associated With Disruptive Behaviours.

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
35 (actual)
Sponsor
University Hospital, Toulouse · Academic / Other
Sex
All
Age
65 Years – 100 Years
Healthy volunteers
Not accepted

Summary

The primary purpose of the protocol is to demonstrate that the use of music therapy may make it possible to discontinue at least one of neuroleptic treatment in patients with AD or related symptoms complicated by behavioral disorders such as agitation and aggressiveness evaluated using the Neuropsychiatric Inventory (NPI). The study hypothesis is that music therapy may have a positive impact on patients with AD complicated by behavioral disorders by reducing the intensity of oppositional behaviour and aggressiveness and allowing a diminution of neuroleptic treatment.

Detailed description

A technique of receptive music therapy to induce relaxation has been developed in the university hospital of Montpellier: the "U" sequence. The musical sequence lasts 20 minutes and is made up of several phases that progressively induce a relaxed state in the patient. This effect is obtained by modulating the rhythm of the music, the orchestral formation, frequencies and volume. The phase of maximum relaxation is followed by a stimulating phase. These musical sequences have been specially designed by the music publishers Music Care©.

Conditions

Interventions

TypeNameDescription
BEHAVIORALMusic therapy"U" sequence: the musical sequence lasts 20 minutes and is made up of several phases that progressively induce a relaxed state in the patient. The phase of maximum relaxation is followed by a stimulating phase.
BEHAVIORALPlaceboInterview with an occupational activity (such as discussion of personal pictures or news) with the caregiver in charge of music therapy sessions with the same period.

Timeline

Start date
2013-04-01
Primary completion
2015-06-01
Completion
2015-06-01
First posted
2013-12-24
Last updated
2018-02-06

Locations

7 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02020356. Inclusion in this directory is not an endorsement.